pharmacists; independent testing; treatment
SB 1214 allows Arizona pharmacists to independently order, perform, and interpret specific health tests (like for flu, strep throat, or COVID-19) and initiate treatment for certain conditions without a doctor's direct order, under a statewide protocol approved by the Arizona State Board of Pharmacy. Pharmacists must use federally approved tests, follow evidence-based guidelines (like CDC recommendations), refer patients to primary care providers if treatment fails or isn't suitable, and notify primary care providers within 72 hours of treatment. The bill requires pharmacists to maintain detailed records for seven years, prohibit opioid treatments, obtain parental consent for minors, and inform patients that care is provided without physician oversight - recommending follow-up with a primary care provider.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2025
Committee Review
Mar 2025
Senate Passage
Mar 2025
House Passage
Governor
Introduced Jan 27, 2025
Last action Apr 15, 2025
Maddy AI version diff · 1 comparison
What changed between versions
Introduced Version
→
Senate Engrossed Version
·
4 edits
·
Mar 3, 2025
MODERATE
This bill was amended to clarify and expand the scope of pharmacists' independent testing and treatment authority in Arizona. The primary changes include raising the minimum age for eligible patients from six to twelve years, adding SARS-CoV-2 and other coronavirus respiratory illnesses to the list of treatable conditions, and updating the committee composition requirements for the advisory committee that will oversee protocol development.
Scope change
The bill's scope was expanded to include coronavirus respiratory illnesses and the age eligibility threshold was increased, making the program applicable to older children and adolescents while broadening the range of conditions pharmacists can address independently.
ELIGIBILITY
The minimum age for patients eligible for pharmacist-initiated testing and treatment was increased from six years to twelve years.
SCOPE
SARS-CoV-2 and other coronavirus respiratory illnesses were added to the list of health conditions pharmacists can independently treat.
REQUIREMENT
The advisory committee composition requirements were updated to specify two physicians specializing in primary care instead of one, and to clarify the language regarding physician specialization and patient demographics.
TECHNICAL
Several formatting and capitalization inconsistencies were corrected throughout the text, including standardizing capitalization of medical terms and section headers.
Floor votes · Senate Mar 3, 2025
How they voted
22–7
Passed · 1 other
Total votes 30
Mar 3, 2025
D
Democratic13
61% Yea
R
Republican17
82% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
11
Key actions
5
Committee
1
Amendments
2
Apr 15, 2025
Lower · Passed
DP
lower
Mar 17, 2025
Lower · Passed
DP
lower
Mar 3, 2025
Upper · Passed
PASSED
upper
Feb 27, 2025
Upper · Passed
DPA
upper
Feb 5, 2025
Upper · Passed
DPA
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
T.J. Shope
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 1214
Scope: AZ
Hi! I can help you understand SB 1214. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline